News & Events:VEEV

PLEASANTON, Calif. Today, most sponsors and CROs use some type of decentralized technology, up 59 percentage points from before the pandemic.

PLEASANTON, Calif. Oncology trials are difficult to execute and demonstrate higher rates of amendment than other studies. With Vault CDMS, data managers can make mid-study amendments without data migration or downtime.

PLEASANTON, Calif. Organizations of all sizes are modernizing pharmacovigilance with the Vault Safety Suite to drive end-to-end processes through better collaboration. "More companies are adopting Veeva Vault Safety Suite applications to drive faster, more efficient case management," said Kelly Traverso, vice president, Veeva Vault Safety strategy.

PLEASANTON, Calif. "We are processing documents more quickly and more efficiently with Veeva Vault eTMF and the TMF Bot," said Stephen van Arcken, senior clinical oversight lead at Cerevel Therapeutics. Automating trial processes with the TMF Bot can reduce the administrative burden on study teams and help alleviate the challenges of misfiled or misclassified documents within the TMF.

Veeva Systems Inc (VEEV): * VEEVA ANNOUNCES DIGITAL TRIALS PLATFORM CONNECTING PATIENTS, SITES, AND SPONSORS Source text for Eikon: Further company coverage:

PLEASANTON, Calif. The comprehensive product offering includes the following core solutions: Each of these solutions are built for the unique needs of patients, sites, and sponsors but connected for seamless execution and flow of data across all stakeholders. The patient consent process provides a good illustration of how the Veeva Digital Trials Platform drives collaboration and data flow.

PLEASANTON, Calif. Veeva (VEEV) will broadcast the presentations live on the company's investor relations website, ir.veeva.com, where a link to the archived webcast will also be available after the event. About Veeva SystemsVeeva (VEEV) is the global leader in cloud software for the life sciences industry.

PLEASANTON, Calif. "COVID-19 limited our time with participants, so we needed new and digital ways to keep our studies moving forward while remaining fully compliant with regulatory requirements regarding obtaining proper consent," said Staci McDonald, executive director, scientific clinical operations at Celerion.

Veeva Systems Inc (VEEV): * LEO PHARMA AND VEEVA SYSTEMS PARTNER FOR PATIENT-CENTRIC DIGITAL TRIALS Source text for Eikon: Further company coverage:

BALLERUP, Denmark and PLEASANTON, Calif. Building on its success with the Veeva Clinical Operations Suite, LEO Pharma will complete its standardization on existing Veeva (VEEV) clinical technology, be an early adopter of future Veeva (VEEV) solutions, and help to shape the Veeva (VEEV) digital trials roadmap.

Veeva Systems Inc (VEEV): * VEEVA ANNOUNCES NEW APPLICATION TO OPTIMIZE QUALITY CONTROL LABS Source text for Eikon: Further company coverage:

PLEASANTON, Calif. "There is a significant opportunity to bring together lab and quality processes for faster, more accurate lab testing," said Brian Brunner, managing director at Accenture. Vault LIMS will enable easy information sharing between lab users and partners and deliver real-time data for more informed decision-making.

Veeva Systems Inc (VEEV): * CONVATEC SELECTS VEEVA VAULT CDMS FOR BIOMARKER STUDY IN WOUND INFECTIONS Source text for Eikon: Further company coverage:

PLEASANTON, Calif. To aid accurate and timely detection of wound infection in clinical practice, ConvaTec and partners have developed a new infection biomarker detection technology based on the combined measurement of the following three biomarkers: wound pH, activity of human neutrophil elastase, and myeloperoxidase host enzymes.

ROCKVILLE, Md. and PLEASANTON, Calif. "Our strategic partnership with Veeva (VEEV) empowers us to streamline how we work, improve visibility and oversight, and run faster, more cost-effective research programs," said Dr. Christine Dingivan, chief executive officer at Emmes.

PLEASANTON, Calif. "Manual validation processes are ineffective, draining resources and increasing operational cost," said Mike Jovanis, vice president of Veeva Vault Quality. Vault Validation Management will reduce manual processes and eliminate silos for better tracking and alignment across validation activities and projects.

PLEASANTON, Calif. Summit Connect is designed to maximize knowledge sharing through interactive sessions and roundtables, featuring more than 75 sessions with global pharmaceutical and biotech leaders at the forefront of transformational change in clinical, regulatory, safety, and quality.

PLEASANTON, Calif. The virtual event will feature more than 15 sessions with quality, regulatory, legal, marketing, and IT experts across North America and Europe.

Veeva Systems Inc (VEEV): * VEEVA ANNOUNCES FISCAL 2022 SECOND QUARTER RESULTS. * SEES Q3 NON-GAAP EARNINGS PER SHARE $0.87 TO $0.88. * Q2 NON-GAAP EARNINGS PER SHARE $0.94. * Q2 EARNINGS PER SHARE $0.67. * SEES Q3 REVENUE $464 MILLION TO $466 MILLION. * SEES FY REVENUE $1.83 BILLION TO $1.835 BILLION. * Q2 REVENUE $455.6 MILLION VERSUS REFINITIV IBES ESTIMATE OF $451.9 MILLION.

PLEASANTON, Calif. "Thanks to the team and the trust of our customers, it was another great quarter," said CEO Peter Gassner. "Rapid innovation is driving expansion in existing markets and significant early traction in newer areas like CDMS and safety as we start to realize the major potential of Veeva Development Cloud."